Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
After finishing at $0.70 in the prior trading day, Werewolf Therapeutics Inc (NASDAQ: HOWL) closed at $0.63, down -9.78%. In other words, the price has decreased by -$9.78 from its previous closing price. On the day, 0.62 million shares were traded. HOWL stock price reached its highest trading level at $0.686 during the session, while it also had its lowest trading level at $0.5951.
Ratios:
Our goal is to gain a better understanding of HOWL by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.45 and its Current Ratio is at 7.45. In the meantime, Its Debt-to-Equity ratio is 0.51 whereas as Long-Term Debt/Eq ratio is at 0.48.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, JMP Securities on April 03, 2024, initiated with a Mkt Outperform rating and assigned the stock a target price of $12.
On August 24, 2023, Wedbush started tracking the stock assigning a Outperform rating and target price of $9.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HOWL now has a Market Capitalization of 28241136 and an Enterprise Value of -42605196. For the stock, the TTM Price-to-Sale (P/S) ratio is 14.94 while its Price-to-Book (P/B) ratio in mrq is 0.38. Its current Enterprise Value per Revenue stands at -22.602 whereas that against EBITDA is 0.594.
Stock Price History:
The Beta on a monthly basis for HOWL is 0.67, which has changed by -0.882243 over the last 52 weeks, in comparison to a change of -0.028342128 over the same period for the S&P500. Over the past 52 weeks, HOWL has reached a high of $6.89, while it has fallen to a 52-week low of $0.70. The 50-Day Moving Average of the stock is -48.31%, while the 200-Day Moving Average is calculated to be -66.52%.
Shares Statistics:
The stock has traded on average 273.07K shares per day over the past 3-months and 345860 shares per day over the last 10 days, according to various share statistics. A total of 44.83M shares are outstanding, with a floating share count of 33.13M. Insiders hold about 26.10% of the company’s shares, while institutions hold 48.12% stake in the company. Shares short for HOWL as of 1741910400 were 2004964 with a Short Ratio of 7.34, compared to 1739491200 on 1865039. Therefore, it implies a Short% of Shares Outstanding of 2004964 and a Short% of Float of 7.5.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
Werewolf Therapeutics Inc (HOWL) is presently subject to a detailed evaluation by 3.0 analysts, each offering their unique perspectives on its market standing.The consensus estimate for the next quarter is -$0.45, with high estimates of -$0.43 and low estimates of -$0.47.
Analysts are recommending an EPS of between -$1.65 and -$1.9 for the fiscal current year, implying an average EPS of -$1.74. EPS for the following year is -$1.46, with 4.0 analysts recommending between -$0.81 and -$2.24.
